- Nigerians have reacted to the supposed death of a citizen to coronavirus because NCDC reportedly did not answer calls
- While many lamented the state of the country and how it handles critical cases, others questioned if calling NCDC was the right action
- There were also those who believed that taking care of oneself or administering DIY treatment is best
Recall that a Nigerian on Twitter with the name Adetutu Balogun cried out after the Nigeria Centre for Disease Control (NCDC) reportedly failed to pick their emergency lines.
The Nigerian said a man named Femi died just because the centre would not pick up their phones when they put repeated calls across to them.
Many have since reacted to her post as they lamented the kind of response structure the centre has in place to attend to people who need swift help.
A Nigerian with the name Okosa said Nigerians should resort to self-help and take their destiny in their own hands in combatting the virus.
Another with the handle @NonsoNaija said with the way things are, he was happy he left Nigeria when he did in 2017.
Others, however, faulted calling NCDC in a situation like that, saying something better could have been done.
Meanwhile, Legit.ng earlier reported that the World Health Organisation (WHO) gave the latest situation report on coronavirus cases in Africa.
In the WHO African update for Tuesday, May 5, the organisation said that the continent now has 46,500 cases and recorded death figures of 1,800.
From the table, South Africa has the highest number of cases with 7,220 and 138 death. It is followed by Algeria with 4,648 cases with the highest number of death at 465.
On the table, Nigeria occupied the third position of countries with 2,802. Ghana and Cameroon are on the 4th and 5th positions with 2,719 and 2,077 cases respectively.
In other news, a round of treatment of Covid-19 using remdesivir, a Gilead Sciences Inc’s newly approved medicine is $4,500 (N1,758,060) according to analysts at Piper Sandler.
It was gathered that the price is the maximum payment the Institute for Clinical and Economic Review asked for a 10-day treatment of the new drug.
PAY ATTENTION: Download our mobile app to enjoy the latest news
The company behind the new medicine has not said anything about its pricing for the coronavirus drug which got approval from US regulators on Friday, May 1.
A Piper Sandler’s analyst, Tyler Van Buren, said that paying $4,500 (N1,758,060) for saving a life “seems really reasonable".
It should be noted that Gilead Sciences Inc. had promised to give out the first 1.5 million vials of the drug. Despite that, the company can generate more than $2 billion (N781,360,000,000) in sales at the end of 2020 going by that price tag.
NAIJ.com (naija.ng) -> Legit.ng We keep evolving to serve our readers better
The Nigerian government cannot handle this pandemic - Woman | Legit TV